Talphera (TLPH) Accumulated Expenses (2010 - 2026)
Talphera's (TLPH) quarterly Accumulated Expenses came in at $2.4 million in Q1 2026, up 141.66% year-on-year from $1.0 million in Q1 2025, and down 6.39% quarter-over-quarter from $2.6 million in Q4 2025.
Talphera (TLPH) Accumulated Expenses (2010 - 2026) Analysis & Trends
Talphera's Accumulated Expenses history runs 17 years deep, the most recent figure standing at $2.4 million for Q1 2026.
- On a quarterly basis, Accumulated Expenses rose 141.66% year-over-year to $2.4 million in Q1 2026; TTM through Mar 2026 was $2.4 million, a 141.66% increase from a year earlier, with the FY2025 full-year figure at $2.6 million, up 108.53% from the prior year.
- Accumulated Expenses retreated to $2.4 million in Q1 2026 per TLPH's latest filing, from $2.6 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $4.4 million in Q3 2022 and bottomed at $1.0 million in Q1 2025.
- The 5-year median for Accumulated Expenses is $1.8 million (2023), against an average of $2.2 million.
- Across the five-year window, Accumulated Expenses plunged 73.45% in 2022 and jumped 141.66% in 2026, its largest moves.
- Year by year, Accumulated Expenses stood at $1.7 million in 2022, then grew by 15.76% to $2.0 million in 2023, then plunged by 37.46% to $1.3 million in 2024, then jumped by 108.53% to $2.6 million in 2025, then fell by 6.39% to $2.4 million in 2026.
- Per Business Quant, the three latest TLPH Accumulated Expenses figures stand at $2.4 million (Q1 2026), $2.6 million (Q4 2025), and $2.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.45 Mn |
| Dec 31, 2025 | 2.62 Mn |
| Sep 30, 2025 | 2.04 Mn |
| Jun 30, 2025 | 1.15 Mn |
| Mar 31, 2025 | 1.01 Mn |
| Dec 31, 2024 | 1.25 Mn |
| Sep 30, 2024 | 1.64 Mn |
| Jun 30, 2024 | 1.74 Mn |
| Mar 31, 2024 | 1.34 Mn |
| Dec 31, 2023 | 2.01 Mn |
| Sep 30, 2023 | 1.79 Mn |
| Jun 30, 2023 | 1.85 Mn |
| Mar 31, 2023 | 1.42 Mn |
| Dec 31, 2022 | 1.73 Mn |
| Sep 30, 2022 | 4.40 Mn |
| Jun 30, 2022 | 4.26 Mn |
| Mar 31, 2022 | 4.32 Mn |
| Dec 31, 2021 | 6.52 Mn |
| Sep 30, 2021 | 5.33 Mn |
| Jun 30, 2021 | 3.98 Mn |